Literature DB >> 2555218

Tyrphostins inhibit the epidermal growth factor receptor-mediated breakdown of phosphoinositides.

I Posner1, A Gazit, C Gilon, A Levitzki.   

Abstract

In response to epidermal growth factor (EGF) and the Ca2+ ionophore A23187, the total phosphatidylinositides (IPT) increased in A431 human epidermoid carcinoma cells 1.8- and 2.0-fold and in the EGF-dependent A431/Clone 15-2 cells 3.0- and 8.0-fold, respectively, over basal levels. Both responses were inhibited by the antiproliferative agents tyrphostins, but the EGF-induced increase in IPT was inhibited to a much greater extent than that induced by the ionophore. Tyrphostins which are potent EGF-receptor kinase inhibitors were also potent in blocking the EGF-induced production of phosphoinositides. The less potent tyrphostins were found to inhibit the EGF-dependent IPT formation more weakly. These results support the notion that phospholipase C is activated through its phosphorylation by the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555218     DOI: 10.1016/0014-5793(89)81554-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Cell-signaling targets for antitumour drug development.

Authors:  V G Brunton; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity.

Authors:  C A Faaland; F H Mermelstein; J Hayashi; J D Laskin
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

3.  The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.

Authors:  A Dvir; Y Milner; O Chomsky; C Gilon; A Gazit; A Levitzki
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.